Research Offers 10-Year Forecast On Orthobiologics Market To 2026
ResearchMoz presents professional and in-depth study of "Orthobiologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026".
The global orthobiologics market was valued at US$ 4.8 Bn in 2017 and is projected expand at a CAGR of 5.5% from 2018 to 2026. High prevalence of sports injuries and arthritis and rise in prevalence of trauma injuries are anticipated to augment the global market between 2018 and 2026. Emerging technologies in orthobiologics is anticipated to drive the market in the region during the forecast period. Additionally, rise in prevalence of sports-related injuries and injuries caused due to falls & accidents propel the market in the region.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=2144381
Global Orthobiologics Market: Overview
This report analyzes the current and future scenario of the global orthobiologics market. Surge in the number of orthopedic procedures, increase in demand for biologics in spinal surgery and traumatic injuries, and rise in prevalence of chronic arthritis are projected to drive the global market. Additionally, rise in prevalence of sports injuries propels the global orthobiologics market.
This report comprises an elaborate executive summary, which includes information about various segments of the global orthobiologics market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global orthobiologics market.
Global Orthobiologics Market: Key Segments
In terms of product, the global orthobiologics market has been segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitutes, viscosupplements, allografts, stem cell, and others. Based on application, the global market has been classified into spinal fusion, trauma repair, reconstructive surgeries, and others. In terms of end-user, the global orthobiologics market has been segmented into hospitals, orthopedic clinics, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Orthobiologics Market: Regional Outlook
In terms of region, the global orthobiologics market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global orthobiologics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in the report include Medtronic, DePuy Synthes (Johnson & Johnson), Sanofi, Seikagaku Corporation, Stryker, MTF Biologics, Bioventus, Arthrex, Zimmer Biomet, RTI Surgical, Inc., Alphatec Spine, Inc., Exactech, Inc., Globus Medical, Inc., and Integra LifeSciences.
The global orthobiologics market has been segmented as below:
Global Orthobiologics Market, by Product
Bone Morphogenetic Proteins
Demineralized Bone Matrix
Synthetic Bone Substitutes
Viscosupplements
Allografts
Stem cell
Others
Global Orthobiologics Market, by Application
Spinal Fusion
Trauma Repair
Reconstructive Surgeries
Others
Global Orthobiologics Market, by End-user
Hospitals
Orthopedic Clinics
Others
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2144381
Global Orthobiologics Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
The global orthobiologics market was valued at US$ 4.8 Bn in 2017 and is projected expand at a CAGR of 5.5% from 2018 to 2026. High prevalence of sports injuries and arthritis and rise in prevalence of trauma injuries are anticipated to augment the global market between 2018 and 2026. Emerging technologies in orthobiologics is anticipated to drive the market in the region during the forecast period. Additionally, rise in prevalence of sports-related injuries and injuries caused due to falls & accidents propel the market in the region.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=2144381
Global Orthobiologics Market: Overview
This report analyzes the current and future scenario of the global orthobiologics market. Surge in the number of orthopedic procedures, increase in demand for biologics in spinal surgery and traumatic injuries, and rise in prevalence of chronic arthritis are projected to drive the global market. Additionally, rise in prevalence of sports injuries propels the global orthobiologics market.
This report comprises an elaborate executive summary, which includes information about various segments of the global orthobiologics market. It also provides information and data analysis of the global market with respect to the segments based on product, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global orthobiologics market.
Global Orthobiologics Market: Key Segments
In terms of product, the global orthobiologics market has been segmented into bone morphogenetic proteins, demineralized bone matrix, synthetic bone substitutes, viscosupplements, allografts, stem cell, and others. Based on application, the global market has been classified into spinal fusion, trauma repair, reconstructive surgeries, and others. In terms of end-user, the global orthobiologics market has been segmented into hospitals, orthopedic clinics, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Orthobiologics Market: Regional Outlook
In terms of region, the global orthobiologics market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players in the global orthobiologics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in the report include Medtronic, DePuy Synthes (Johnson & Johnson), Sanofi, Seikagaku Corporation, Stryker, MTF Biologics, Bioventus, Arthrex, Zimmer Biomet, RTI Surgical, Inc., Alphatec Spine, Inc., Exactech, Inc., Globus Medical, Inc., and Integra LifeSciences.
The global orthobiologics market has been segmented as below:
Global Orthobiologics Market, by Product
Bone Morphogenetic Proteins
Demineralized Bone Matrix
Synthetic Bone Substitutes
Viscosupplements
Allografts
Stem cell
Others
Global Orthobiologics Market, by Application
Spinal Fusion
Trauma Repair
Reconstructive Surgeries
Others
Global Orthobiologics Market, by End-user
Hospitals
Orthopedic Clinics
Others
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2144381
Global Orthobiologics Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Comments
Post a Comment